Ronovo Surgical
Ronovo Surgical is a Shanghai-based medtech company that develops and commercializes the Haishan-1 modular laparoscopic surgical robot system, serving top-tier hospitals across general surgery, urology, gynecology, and thoracic surgery applications in China and select international markets.
- Company typePrivate
- Founded2019
- HeadquartersShanghai, China
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ronovo Surgical does
Ronovo Surgical (瑞龙外科/瑞龙诺赋) is a Shanghai-based medical technology company founded in November 2019 by Dr. Ma Changzheng (former Intuitive Surgical SVP) and Dr. Mao Ying (former Auris Health control algorithm lead) to develop modular, accessible laparoscopic surgical robots for the Chinese and global markets. Its flagship product, the Haishan-1 (海山一) modular laparoscopic surgical robot system, received NMPA market approval in March 2025 as China's first domestically developed modular surgical robot and the first surgical robot cleared for all four core specialties—general surgery, thoracic surgery, gynecology, and urology—upon initial registration. The platform's defining architectural feature is a split-type design that separates robotic arms into independently deployable mobile carts, enabling flexible OR layouts, a footprint of approximately 35 square meters, single-docking cross-quadrant procedures, and compatibility with both robotic wristed instruments and traditional straight-shaft laparoscopic tools.
The company generates revenue through sale of Haishan-1 robot systems to top-tier Chinese hospitals, recurring surgical instrument revenue (single-use wristed and reusable straight-shaft instruments), and clinical training services delivered through its Yangzhou global production base. Distribution combines direct enterprise sales to tier-3A hospitals and academic medical centers across major Chinese cities with a September 2025 strategic partnership with Johnson & Johnson MedTech that provides access to J&J's established hospital channel and clinical education infrastructure in China. International expansion is pursued through CE certification for Europe and ANVISA for Latin America, anchored by the RISE (Ronovo Institute for Surgical Excellence) clinical research center in Orlando, Florida and the first Latin American commercial deployment at Clinica Monterrico in Peru (April 2026).
The company has filed more than 200 patents, employs 300+ professionals (65%+ holding graduate or doctoral degrees), and has cumulatively raised over $100M across multiple funding rounds, with the September 2025 $67M Series D led by Johnson & Johnson Development Corporation marking the most recent capital event. Over 600 clinical surgeries have been completed across multiple specialties with a reported 100% trial success rate. The Yangzhou production base, operational since April 2025, provides designed annual capacity of 500 surgical robot systems and 500,000 surgical instrument sets.
Ronovo Surgical firmographics
Firmographics- Name
- Ronovo Surgical
- Legal name
- 瑞龙诺赋（上海）医疗科技有限公司
- Website
- https://ronovo.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Ronovo Surgical is a Shanghai-based medtech company that develops and commercializes the Haishan-1 modular laparoscopic surgical robot system, serving top-tier hospitals across general surgery, urology, gynecology, and thoracic surgery applications in China and select international markets.
- Ownership category
- akta.pro rank
Ronovo Surgical industry classification
Industry- Product category
- Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE), Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD), Healthcare & Assistive Robotics (HDAAAIAC)
Keywords
Where Ronovo Surgical is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Offices3 records
Markets served
Ronovo Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Surgical Robot System Sales: Sale of Haishan-1 modular surgical robot systems to hospitals, including configurable cart quantities and instrument sets
- Surgical Instruments and Consumables: Single-use wristed instruments and reusable straight-shaft instruments, with consumable revenue generated per procedure
- Clinical Training and Services: Training programs for surgeons and clinical support services through the Yangzhou global production base training center
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Ronovo Surgical product offering
Product offeringCore offering
Ronovo Surgical designs, manufactures, and commercializes the Haishan-1® modular laparoscopic surgical robot system, including its integrated 3D vision platform and surgical instrument portfolio, for sale to hospitals and medical centers. The company's modular split-type architecture enables flexible cart-based deployment of robotic arms across operating rooms, supporting minimally invasive procedures in general surgery, urology, gynecology, and thoracic surgery. Revenue is generated through system sales, recurring consumables (instruments), and clinical training services.
Product overview
Ronovo Surgical offers a modular, platform-based product portfolio centered on the Haishan-1® modular laparoscopic surgical robot system. The core platform consists of independently deployable modular trolleys with robotic arms that can be flexibly configured (3–5 arms) per surgical specialty and procedure type, combined with a surgeon console, electronic hub, and instrument accessories. The product line is supplemented by the Haishan-1® laparoscopic vision system (integrating 4K 3D and ICG fluorescence imaging) and a suite of surgical instruments including wristed and straight-shaft options. An add-on remote surgery ecosystem enables cross-regional surgical mentoring and tele-operation. Together, these products constitute an integrated, modular surgical robotics platform designed to serve general surgery, thoracic surgery, gynecology, and urology.
Differentiator
Problem solved
Functional benefit
Brands
- 海山一® (Haishan-1 / Carina™): China's first approved modular/lump-separated (分体式) laparoscopic surgical robot system, cleared for General Surgery, Urology, Gynecology, and Thoracic Surgery. Features modular cart design, flexible arm configuration, and compatibility with both wristed and straight instruments.
- RISE瑞龙国际临床卓越中心 (Ronovo Institute for Surgical Excellence)
- Carina™ Platform
Products and services
- Haishan-1® Modular Laparoscopic Surgical Robot System (海山一®分体式腔镜手术机器人系统) China's first domestically developed modular laparoscopic surgical robot featuring a split, modular architecture that separates robotic arms into independent trolley units, allowing flexible positioning, variable arm counts (3–5 arms), and rapid redeployment across operating rooms. NMPA-approved for general surgery, thoracic surgery, gynecology, and urology, designed for hospitals seeking flexible and cost-effective robotic surgery platforms.
- Haishan-1® Laparoscopic Vision System (海山一®腔镜视觉系统) Integrated imaging module for the Haishan-1 surgical robot platform, incorporating 4K resolution, 3D stereoscopic visualization, and ICG (indocyanine green) fluorescence imaging with real-time blood flow perfusion assessment, tumor margin analysis, and anatomical structure identification capabilities.
- Haishan-1® Surgical Instruments (海山一®手术器械) Surgical instrument portfolio for the Haishan-1 platform including wristed instruments (8mm) with enhanced articulation and straight-shaft instruments (5mm) for cost-effective procedures. Compatible with traditional laparoscopic instruments and the modular robotic system; supports multiple surgical disciplines.
- Ronovo Surgical Remote Surgery Ecosystem (Remote Surgical Assistance Platform) A remote surgery platform enabling remote digital surgical mentoring and tele-surgery capabilities, supporting mentor-guided operation modes and demonstration modes for cross-regional surgical skill transfer, with latency controlled within 20ms over standard broadband networks.
Quantifiable outcome
- 600+ successful clinical surgeries completed across 5 specialties as of end of 2025
- +4 more outcomes
Companies that use Ronovo Surgical
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles1 record
Ronovo Surgical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability1 record
Feature5 records
Ronovo Surgical partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered regional, significant and core.
- Clinica Monterrico, PeruregionalFirst Latin America commercial deployment and training center establishment for Spanish-speaking surgeon training in modular robotic surgery.
- 大连理工大学医学部 (DUT Medical School)significantIndustry-education partnership for talent cultivation, clinical research collaboration, and curriculum development related to surgical robotics.
- Johnson & Johnson MedTech (强生医疗科技)coreStrategic collaboration signed September 2025 to combine Ronovo's Haishan-1 modular surgical robot platform with J&J MedTech's minimally invasive surgery expertise. Partnership targets offering comprehensive digital minimally invasive surgery solutions to healthcare institutions in China. This marks J&J's first strategic partnership with a domestic surgical robot company.
- 扬州大学附属医院 (Yangzhou University Affiliated Hospital)significantStrategic cooperation signed for clinical research collaboration, talent development, and promotion of surgical robot clinical applications.
- AdventHealth Nicholson CentercorePartnership to establish RISE (Ronovo Institute for Surgical Excellence) international clinical research center in Orlando, leveraging AdventHealth's surgical training infrastructure.
- GE Healthcare China (GE医疗中国)significantFirst batch company to join GE Healthcare's largest 'Innovation Center' in Shanghai Zhangjiang, focusing on digital medical imaging integration with surgical robotics.
Scale indicators7 records
Recent moves10 records
Expansion highlights7 records
Ronovo Surgical competitors and assessment
Company assessmentBroad incumbents
- Intuitive Surgical: Global incumbent in robotic-assisted surgery with the da Vinci platform. Direct competitor in laparoscopic/soft-tissue robotic surgery across the same four specialties (general, urology, gynecology, thoracic) that Ronovo targets, with a dominant installed base in tier-1 Chinese hospitals.
- Medtronic: Global medtech incumbent developing the Hugo robotic-assisted surgery platform. Competes in laparoscopic robotic surgery worldwide and is partnering with Ronovo-adjacent stakeholders, shaping the competitive context for Ronovo's international expansion.
- Johnson & Johnson MedTech: Strategic partner of Ronovo and a competitor via the Ottava general-surgery robotics platform. The dual relationship creates both a major distribution advantage and a channel-conflict risk for Ronovo's international expansion.
- Stryker (Mako): Global medtech incumbent with the Mako orthopedic surgical robot and an emerging presence in soft-tissue robotics. Relevant as a broad incumbent in surgical robotics that competes for hospital capital budgets and OR integration contracts.
Direct peers
- Shurui Robot (术锐机器人): Chinese domestic competitor developing single-port and modular endoscopic surgical robots with NMPA approvals. Targets the same Chinese hospital market and minimally invasive surgery applications as Ronovo's Haishan-1.
- Edge Medical Robotics (精锋医疗): Chinese surgical robotics company with NMPA-approved laparoscopic and orthopedic robot systems. Competes head-to-head in the Chinese modular/multi-port robotic surgery market against Ronovo.
- Touch Surgery (Toumai): Chinese laparoscopic surgical robot company with NMPA-cleared systems, commercial deployments in Chinese hospitals, and overlapping specialty indications. Closest direct peer in the China multi-port modular robot category.
- CMR Surgical: UK-based developer of the Versius modular surgical robot — a small-form-factor, modular-cart design that competes on the same portability, footprint, and cost-flexibility thesis as Ronovo's Haishan-1, targeting global markets.
Emerging players
- Meere Company (Revo-i): Korean developer of the Revo-i laparoscopic surgical robot with regulatory approvals in multiple countries. Comparable modular-style platform competing for emerging-market and Asian hospital customers in the same specialty segments.
- Vicarious Surgical: U.S. developer of a next-generation robotic surgery platform using decoupled/portable architecture. Comparable in pursuing a fundamentally different form-factor and deployment model than monolithic incumbents, though still pre-commercial.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Ronovo Surgical social profiles
Digital presenceRonovo Surgical compliance and trust
Trust signalCompliance1 record
Ronovo Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ronovo Surgical leadership team
Management profileNumber of profiles
Profiles1 record
Ronovo Surgical subsidiaries and ownership
Company hierarchySubsidiaries2 records
Ronovo Surgical funding detail
Funding detailFunding overview
Funding rounds7 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ronovo Surgical M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ronovo Surgical
What does Ronovo Surgical do?
Ronovo Surgical designs, manufactures, and commercializes the Haishan-1® modular laparoscopic surgical robot system, including its integrated 3D vision platform and surgical instrument portfolio, for sale to hospitals and medical centers. The company's modular split-type architecture enables flexible cart-based deployment of robotic arms across operating rooms, supporting minimally invasive procedures in general surgery, urology, gynecology, and thoracic surgery. Revenue is generated through system sales, recurring consumables (instruments), and clinical training services.
Is Ronovo Surgical a public or private company?
Ronovo Surgical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Ronovo Surgical founded?
Ronovo Surgical was founded in 2019. It employs 101 to 250 people.
Where is Ronovo Surgical based?
Ronovo Surgical is headquartered in Shanghai, China, in the Asia region.
How does Ronovo Surgical make money?
Three revenue lines are on record. Surgical Robot System Sales are the primary driver. The others are surgical Instruments and Consumables and clinical Training and Services.
Who are Ronovo Surgical's main competitors?
Broad incumbents on record are Intuitive Surgical, Medtronic, Johnson & Johnson MedTech and Stryker (Mako). Direct peers are Shurui Robot (术锐机器人), Edge Medical Robotics (精锋医疗), Touch Surgery (Toumai) and CMR Surgical. Emerging players are Meere Company (Revo-i) and Vicarious Surgical.
Does Ronovo Surgical have an API?
No public API is recorded for Ronovo Surgical.
What industry is Ronovo Surgical in?
Ronovo Surgical's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAE, Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity). Its NAICS code is 339112 and its SIC code is 3841.